[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352308-105":59,"doc-detail-352308-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evolution-or-revolution-in-colorectal-cancer-treatment-present-and-future-of-new-therapeutic-options-a-narrative-review","Evolution or Revolution in Colorectal Cancer Treatment: Present and Future of New Therapeutic Options - A Narrative Review","","Colorectal cancer (CRC) is the third most common malignancy worldwide and a major cause of cancer-related mortality, with rising incidence projected by 2050 due to population aging and increased exposure to risk factors in developing regions. Although medicine and pharmacy have advanced, current treatments show limited effectiveness, creating an urgent need for innovative strategies. This narrative review evaluates existing CRC therapies while examining emerging directions, especially immunotherapy, targeted therapy, nanotechnology, metal-based compounds, PROTAC approaches, and personalized medicine, focusing on efficacy, safety, mechanisms of resistance, and access. Surgery and chemotherapy remain foundational, but novel approaches aim to improve tolerability and survival while addressing toxicity, resistance, and access inequities through translational research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evolution-or-revolution-in-colorectal-cancer-treatment-present-and-future-of-new-therapeutic-options-a-narrative-review/352308/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evolution-or-revolution-in-colorectal-cancer-treatment-present-and-future-of-new-therapeutic-options-a-narrative-review/352308.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the review emphasize about colorectal cancer treatment outcomes?","Question",{"text":112,"@type":113},"It notes that despite medical advances, the effectiveness of available therapies is still limited, motivating new therapeutic strategies that can improve tolerability and survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which emerging CRC approaches does the review highlight?",{"text":117,"@type":113},"The review specifically discusses immunotherapy, targeted therapies, nanotechnology-based methods, metal-based compounds, PROTAC technology, and personalized medicine.",{"name":119,"@type":110,"acceptedAnswer":120},"How is metastatic spread and clinical stage typically understood in colorectal cancer?",{"text":121,"@type":113},"It explains that metastasis arises from migration of cancer cells to distant organs via blood vessels or lymphatics, and that clinical staging uses TNM classification to define early (I–II) versus advanced (III–IV) disease.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352308,1791187747,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Tech Science Press  \n| Doi:10.32604/or.2025.067449\u003Cbr>REVIEW | \u003Cbr>|\n| --- | --- |\n| Evolution or Revolution in Colorectal Cancer Treatment: Present and Future of NewTherapeutic Options. A Narrative Review\u003Cbr>Urszula Czcik1,2,\\#, Martyna Gryglas3, Arkadiusz Szterk4 and SylwiaFlis3, *,\\#\u003Cbr>1 Centre of Postgraduate Medical Education, Doctoral School of Translational Medicine, Marymoncka 99, Warsaw, 01-813, Poland 2 Center of Translational Medicine, Warsaw University of Life Science, Nowoursynowska 100, Warsaw, 02-797, Poland\u003Cbr>3 Division of Pharmacology and Toxicology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland\u003Cbr>4 ASLAB Science P.S.A., Fort Słuew 1/9, Warsaw, 02-787, Poland\u003Cbr>*[Corresponding Author: Sylwia Flis. Email: sylwia_flis@sggw.edu.pl](Corresponding Author: Sylwia Flis. Email: sylwia_flis@sggw.edu.pl)\u003Cbr>\\# These authors contributed equally to this work\u003Cbr>Received: 04 May 2025; Accepted: 11 October 2025; Published: 19 January 2026\u003Cbr>ABSTRACT: Colorectal cancer (CRC) is the third most common malignancy worldwide and the second leading cause of cancer-related deaths, accounting for approximately 10% of all cancer cases. By 2050, CRC incidence is expected to rise substantially, driven by population aging and greater exposure to risk factors in developing countries. Despite advances in medicine and pharmacy, the effectiveness of available treatments remains limited, underscoring the urgent need for innovative therapeutic strategies. This review summarizes and critically evaluates currently available CRC therapies and explores new emerging directions. Particular attention is given to the role of immunotherapy, targeted therapies, nanotechnology-based approaches, metal-based compounds, PROTAC technology, and personalized medicine, with emphasis on their efficacy, safety, accessibility, and mechanisms of drug resistance. In conclusion, surgery and chemotherapy remain the backbone ofCRC treatment, but novel therapeutic approaches are reshaping the treatment landscape. Emerging strategies may offer improved patient tolerability and survival outcomes by reducing the occurrence of burdensome adverse effects. Persistent challenges such as drug toxicity, the emergence of resistance mechanisms, and inequalities in access to innovative therapies underscore the need for further translational research. Integrating personalized therapeutic approaches will also be crucial to achieving more effective, safer, and accessible treatment strategies for CRC.\u003Cbr>KEYWORDS: Colorectal cancer (CRC); treatment; chemotherapy; innovative therapeutic strategies |  |\n\n1 Introduction  \nColorectal cancer (CRC) develops in the colon or rectum, which form essential components of the digestive system. The process of carcinogenesis proceeds in several stages, starting with benign lesions, such as adenomatous polyps, which, as a result of the accumulation of genetic mutations involving the APC, KRAS, TP53 genes, and the DNA mismatch repair (MMR) pathways, can transform into invasive lesions [1] . Colorectal cancer is the third most frequently diagnosed cancer in the world and one of the leading causes of cancer-related deaths. According to the Global Cancer Observatory (GLOBOCAN), in 2020, there were over 1.9 million new cases and about 935,000 deaths associated with CRC [2] . The incidence is highest in industrialized nations, especially Western Europe, Australia, and New Zealand, while the highest mortality rates are reported in Eastern Europe [2] . In the United States, CRC ranks fourth in incidence in both men  \nCopyright © 2026 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nand women. Annually, approximately 150,000 Americans are diagnosed w","cbCaigPypE2tiDgC","https://ap.wps.com/l/cbCaigPypE2tiDgC","pdf",5100235,25,"English","# 1 Introduction\n## Colorectal cancer burden and epidemiology\n## Metastasis and clinical presentation\n## Staging and TNM classification","[{\"question\":\"What does the review emphasize about colorectal cancer treatment outcomes?\",\"answer\":\"It notes that despite medical advances, the effectiveness of available therapies is still limited, motivating new therapeutic strategies that can improve tolerability and survival.\"},{\"question\":\"Which emerging CRC approaches does the review highlight?\",\"answer\":\"The review specifically discusses immunotherapy, targeted therapies, nanotechnology-based methods, metal-based compounds, PROTAC technology, and personalized medicine.\"},{\"question\":\"How is metastatic spread and clinical stage typically understood in colorectal cancer?\",\"answer\":\"It explains that metastasis arises from migration of cancer cells to distant organs via blood vessels or lymphatics, and that clinical staging uses TNM classification to define early (I–II) versus advanced (III–IV) disease.\"}]","Evolution or Revolution in Colorectal Cancer Treatment: Present and Future of New Therapeutic Options - A Narrative Review | PDF",1790098849,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2559f4010c558802ae3b67ec25f91d0.webp",983,1271,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76405ad6de17849408829bf99ad91d4e.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab0020efe8c021ac918463fb82519559.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c87646bb57259d0fd763cc1b45396b00.webp",980,1267]